Adverse drug reactions during heatwaves.
Patients receiving the following drugs should be closely monitored during heatwaves: psychotropics, atropinics, amphetamine-like drugs, parasympathomimetic agents such as cholinesterase inhibitors, thyroid hormones, drugs that increase the risk of renal failure in case of dehydration, and betablockers.
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects; D000662:Amphetamines / Q000009:adverse effects; D047228:Angiotensin II Type 1 Receptor Blockers / Q000009:adverse effects; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects; D001285:Atropine / Q000009:adverse effects; D004232:Diuretics / Q000009:adverse effects; D064420:Drug-Related Side Effects and Adverse Reactions; D005602:France; D006358:Hot Temperature / Q000009:adverse effects*; D006801:Humans; D010277:Parasympathomimetics / Q000009:adverse effects; D011619:Psychotropic Drugs / Q000009:adverse effects; D013963:Thyroid Hormones / Q000009:adverse effects; D014887:Weather
D000319:Adrenergic beta-Antagonists; D000662:Amphetamines; D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D000894:Anti-Inflammatory Agents, Non-Steroidal; D004232:Diuretics; D010277:Parasympathomimetics; D011619:Psychotropic Drugs; D013963:Thyroid Hormones; D001285:Atropine